# CytoGam for CMV Infection or Disease in Solid Organ Transplant Recipients

> **NCT07009548** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Fernanda P Silveira, MD, MS** · enrollment: 45 (estimated)

## Conditions studied

- Cytomegalovirus (CMV) Infection

## Interventions

- **DRUG:** Cytogam

## Key facts

- **NCT ID:** NCT07009548
- **Lead sponsor:** Fernanda P Silveira, MD, MS
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-06-26
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2025-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07009548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07009548, "CytoGam for CMV Infection or Disease in Solid Organ Transplant Recipients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07009548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*